New Developments in Follicular Lymphoma: Treatment Guidance and Clinical Resources

Get up to date on optimal management of follicular lymphoma with multidisciplinary expert perspectives on selecting frontline therapy, sequencing treatments for relapsed or refractory disease, and utilizing rituximab biosimilars and alternative formulations, along with promising investigational agents.

Emily Bucholtz, RPh Nichole Fisher, RN, BSN Jeff P. Sharman, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Registered Nurses: 1.25 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Released: November 20, 2020 Expired: November 19, 2021

How will you incorporate tazemetostat, an EZH2 inhibitor, into your clinical practice for patients with relapsed/refractory follicular lymphoma? Here are my thoughts.

John M. Burke, MD Released: August 4, 2020

Read this expert commentary for an overview of our updated treatment decision support tool for follicular lymphoma that provides treatment recommendations from 5 lymphoma experts for your patients with newly diagnosed and relapsed/refractory disease.

Christopher R. Flowers, MD, MS Released: March 18, 2021

Download this PDF clinical resource to help optimize care of your patients with follicular lymphoma, including a treatment algorithm for newly diagnosed and relapsed/refractory disease and a toxicity management table.

Emily Bucholtz, RPh Nichole Fisher, RN, BSN Released: September 30, 2020

Download this ExpressPoints slideset for a quick summary of the latest clinical data informing optimal management of newly diagnosed and relapsed/refractory follicular lymphoma.

Emily Bucholtz, RPh Nichole Fisher, RN, BSN Jeff P. Sharman, MD Released: October 14, 2020

Download this slideset to review the latest clinical data informing optimal management strategies for both newly diagnosed and relapsed/refractory follicular lymphoma, including a peek at novel therapies under investigation.

Emily Bucholtz, RPh Nichole Fisher, RN, BSN Jeff P. Sharman, MD Released: October 14, 2020

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with newly diagnosed or relapsed/refractory follicular lymphoma with those of 5 renowned lymphoma experts.

John M. Burke, MD Ian W. Flinn, MD, PhD Christopher R. Flowers, MD, MS John P. Leonard, MD Jeff P. Sharman, MD Released: March 1, 2021